Clopidogrel and Haematocrit - a phase IV clinical study of FDA data

Summary:

Haematocrit is reported as a side effect among people who take Clopidogrel (clopidogrel), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Jakafi, and have Polycythaemia vera.

The phase IV clinical study analyzes which people have Haematocrit when taking Clopidogrel. It is created by eHealthMe based on reports of 91,038 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Haematocrit?

Haematocrit is found to be associated with 275 drugs and 575 conditions by eHealthMe. Check the latest studies of Haematocrit.

On Jul, 10, 2026

91,038 people reported to have side effects when taking Clopidogrel.
Among them, 29 people (0.03%) have Haematocrit.

Among these 29 people:

How long have people been on Clopidogrel when they have Haematocrit? *

What is the gender of people who have Haematocrit when taking Clopidogrel? *

female: 13.33 %
male: 86.67 %

What is the age of people who have Haematocrit when taking Clopidogrel? *

What are other drugs people take besides Clopidogrel? *

What are other side effects people have besides Haematocrit? *

Weakness: 24 people, 82.76%
Dry Skin: 22 people, 75.86%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 22 people, 75.86%
Fatigue (feeling of tiredness): 22 people, 75.86%
Constipation: 22 people, 75.86%
Nausea (feeling of having an urge to vomit): 22 people, 75.86%
Dyspnea (difficult or laboured breathing): 21 people, 72.41%
Malaise (a feeling of general discomfort or uneasiness): 21 people, 72.41%
Confusional State: 20 people, 68.97%
Headache (pain in head): 19 people, 65.52%

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 23 people, 79.31%
Panic Disorder: 17 people, 58.62%
Insomnia (sleeplessness): 16 people, 55.17%
Primary Myelofibrosis (primary disorder of the bone marrow): 8 people, 27.59%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 6.90%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 1 person, 3.45%
Sleep Disorder: 1 person, 3.45%
Breast Cancer: 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and have Haematocrit?

- Check whether Haematocrit is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopidogrel:

Clopidogrel (92,160 reports)

Haematocrit treatments and more:

Haematocrit (407 reports)

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematocrit:

Haematocrit (275 drugs)

Browse all the conditions that are associated with Haematocrit:

Haematocrit (575 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.